Trapelo Health operates in the precision medicine market, offering an interoperable decision support platform that serves oncologists, labs, and payers. The platform facilitates real-time alignment in precision medicine by informing testing and treatment decisions, streamlining workflows, and eliminating the need for traditional prior authorization. This enables value-based care and ensures that cancer patients receive the most appropriate, evidence-supported options quickly. Trapelo Health's business model revolves around providing a subscription-based service to healthcare providers and payers, generating revenue through recurring fees. The company's core clients include oncologists, healthcare providers, laboratories, and insurance payers. By leveraging its technology, Trapelo Health aims to standardize value-based precision medicine, improve patient outcomes, and connect more cancer patients to new therapies and clinical trials.

Keywords: precision medicine, decision support, oncology, real-time alignment, value-based care, genomic testing, evidence-based, healthcare technology, cancer treatment, clinical trials.